Skip to the page

Data / Form D filings / Juvena Therapeutics, Inc.

Juvena Therapeutics, Inc.: Form D filings

Juvena Therapeutics, Inc., a technology company in Redwood City, CA, filed 2 Form D notices with the SEC between 2018 and 2025. The latest, on July 25, 2025, reports $30.5 million sold of a $41 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
640 GALVESTON DRIVE, Redwood City, CA, 94063
Phone
(914) 560-6536
Industry
Other Technology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1732720

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 25, 2025New notice$41,000,000$30,493,884$10,506,11612Jun 27, 2025sec.gov
Feb 26, 2018New notice$4,325,000$4,314,989$10,01123Feb 7, 2018sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Steven JamesDirector
Ben HemaniDirector
Stephen JuelsgaardDirector
Hanadie YousefExecutive Officer, Director
Laura Lande-DinerDirector
Christopher KirkDirector
Ayman AlAbdallahDirector
Jeremy O'ConnellDirector

Other technology companies in California that filed recently

Every Form D from the week of Jul 21, 2025 · All recent filings in California · All recent Other Technology filings

Read from SEC EDGAR. Amount sold is what Juvena Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.